Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Oct 1;50(10):e617-e620.
doi: 10.1097/RLU.0000000000005825. Epub 2025 Mar 10.

18F-Fluorocholine PET/CT for the Staging and Follow-up of a Patient Suffering From Metastatic Parathyroid Carcinoma

Affiliations
Case Reports

18F-Fluorocholine PET/CT for the Staging and Follow-up of a Patient Suffering From Metastatic Parathyroid Carcinoma

Margaux Brument et al. Clin Nucl Med. .

Abstract

Parathyroid carcinoma (PC) is a rare disease, with a frequency of 0.005% of all malignancies. Approximately 30% of patients will develop metastases at some point in the disease. Nonsecreting PC represents <10% of all PC and is harder to diagnose. Here, we report the case of a patient suffering from metastatic nonsecreting PC who has been (and still is) monitored for 4.5 years with 18F-fluorocholine PET/CT.

Keywords: PET/CT; follow-up; parathyroid carcinoma; staging.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: none declared.

References

    1. Fingeret AL. Contemporary evaluation and management of parathyroid carcinoma. JCO Oncol Pract. 2021;17:17–21.
    1. Alberti A, Smussi D, Zamparini M, et al. Treatment and outcome of metastatic parathyroid carcinoma: a systematic review and pooled analysis of published cases. Front Oncol. 2022;12:997009.
    1. Morand GB, Helmchen BM, Steinert HC, et al. 18F-Choline-PET in parathyroid carcinoma. Oral Oncol. 2018;86:314–315.
    1. Deandreis D, Terroir M, Al Ghuzlan A, et al. 18Fluorocholine PET/CT in parathyroid carcinoma: a new tool for disease staging? Eur J Nucl Med Mol Imaging. 2015;42:1941–1942.
    1. Hatzl M, Röper-Kelmayr JC, Fellner FA, et al. 18F-Fluorocholine, 18F-FDG, and 18F-Fluoroethyl Tyrosine PET/CT in parathyroid cancer. Clin Nucl Med. 2017;42:448–450.

Publication types

LinkOut - more resources